Infection biomarkers in primary care patients with acute respiratory tract infections–comparison of Procalcitonin and C-reactive protein

Abstract

BackgroundThere is a lack of studies comparing the utility of C-reactive protein (CRP) with Procalcitonin (PCT) for the management of patients with acute respiratory tract infections (ARI) in primary care. Our aim was to study the correlation between these markers and to compare their predictive accuracy in regard to clinical outcome prediction.MethodsThis is a secondary analysis using clinical and biomarker data of 458 primary care patients with pneumonic and non-pneumonic ARI. We used correlation statistics (spearman’s rank test) and multivariable regression models to assess association of markers with adverse outcome, namely days with restricted activities and persistence of discomfort from infection at day 14.ResultsAt baseline, CRP and PCT did not correlate well in the overall population (r2 = 0.16) and particularly in the subgroup of patients with non-pneumonic ARI (r2 = 0.08). Low correlation of biomarkers were also found when comparing cut-off ranges, day seven levels or changes from baseline to day seven. High baseline levels of CRP (>100 mg/dL, regression coefficient 1.6, 95 % CI 0.5 to 2.6, sociodemographic-adjusted model) as well as PCT (>0.5ug/L regression coefficient 2.0, 95 % CI 0.0 to 4.0, sociodemographic-adjusted model) were significantly associated with larger number of days with restricted activities. There were no associations of either biomarker with persistence of discomfort at day 14.ConclusionsCRP and PCT levels do not well correlate, but both have moderate prognostic accuracy in primary care patients with ARI to predict clinical outcomes. The low correlation between the two biomarkers calls for interventional research comparing these markers head to head in regard to their ability to guide antibiotic decisions.Trial registrationCurrent Controlled Trials, ISRCTN73182671Electronic supplementary materialThe online version of this article (doi:10.1186/s12890-016-0206-4) contains supplementary material, which is available to authorized users.

Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis

“…Studies comparing procalcitonin and C-reactive protein have reported low correlation of these markers suggesting that important differences exist, which could lead to different recommendations on antibiotic use in individual patients. 62,63 However, head-tohead studies assessing the clinical effect of procalcitonin compared with C-reactive protein guided treatment algorithms are still needed. Finally, one strategy that has had an impact in the inpatient setting is early provider notification of procalcitonin results and this strategy might improve the performance of procalcitonin-guided treatment algorithms if used in future studies done in primary care settings.…”

Procalcitonin-guided diagnosis and antibiotic stewardship revisited

“…We have also not discussed in detail other markers of infection such as CRP. However, there is a lack of well-done and large studies comparing the effect of both markers when used in the context of antibiotic stewardship [82, 83]. …”

Five Predictors Affecting the Prognosis of Patients with Severe Odontogenic Infections

“…Nevertheless, most studies failed to objective correlation between CRP level and severity of the sepsis [21]. Meili et al, (2016), demonstrated that CRP < 100 mg/l is signi cantly associated with worst acute respiratory tract infections but have moderate prognostic accuracy in primary care patients to predict clinical outcomes [22]. CRP help to diagnose equivocal cases of appendicitis, cholecystitis, pancreatitis and pelvic in ammatory disease but faster and more interpretable tests are available.…”